The performance of companies tied to the drug's past presents a complex investment landscape. While the initial boom generated substantial returns , generic competition have significantly eroded revenue. https://mypresspage.com/story6738629/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-opportunity